Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Down 20%: Ariad Pharmaceuticals' Second Dose of Bad News
Motley Fool
Saturday, October 12, 2013 - 10:34am
tags:
Ariad Pharma
Data on Auxilium Pharma's Xiaflex
Yahoo/Zacks
Saturday, October 12, 2013 - 10:27am
tags:
Auxilium, Xiaflex, Dupuytren's Contracture
Is Questcor a Good Investment?
Motley Fool
Saturday, October 12, 2013 - 10:25am
tags:
Questcor Pharmaceuticals
KV's first steps after emerging from bankruptcy
Bizjournals.com
Friday, October 11, 2013 - 12:16pm
tags:
KV Pharmaceutical, bankruptcy
Med tech's hottest takeover targets for the rest of 2013
Fierce Medical Devices
Friday, October 11, 2013 - 12:14pm
tags:
devices, Baxter International, Mako Surgical, KKR, M&A
FDA's Woodcock: I'm not going anywhere
Fierce Biotech
Friday, October 11, 2013 - 12:08pm
tags:
FDA, Janet Woodcock
Nicotine patch maker LTS Lohmann attracts bidders
Reuters
Friday, October 11, 2013 - 11:45am
tags:
nicotine patch, smoking cessation, LTS Lohmann, M&A, Hisamitsu
Endocyte falls after panel says cancer drug isn't working better than older treatment in study
Yahoo/AP
Friday, October 11, 2013 - 11:44am
tags:
Endocyte, vintafolide, Docetaxel, ovarian cancer, breast cancer
First of Its Kind Study Design Raises the Bar for Scientific Rigor in Drug-Coated Balloons
Yahoo
Friday, October 11, 2013 - 9:45am
tags:
drug-coated balloons, devices, Lutonix, CR Bard, peripheral artery disease
Medical device tax: Is the White House changing its tone?
Mass Device
Friday, October 11, 2013 - 9:40am
tags:
device tax, healthcare reform, devices
Osiris exits stem cell business, sells unit to Mesoblast in $100M deal
Fierce Biotech
Friday, October 11, 2013 - 9:39am
tags:
Mesoblast, Osiris, stem cells, M&A
Psoriasis study does little to help Pfizer with Xeljanz
Fierce Pharma
Friday, October 11, 2013 - 9:37am
tags:
Pfizer, psoriasis, Xeljanz
Analysts' Actions: AIZ GLW JNJ LLY MRK
Yahoo/TheStreet.com
Friday, October 11, 2013 - 9:35am
tags:
JNJ, Eli Lilly, Merck, Pharmacyclics
Celladon, Xencor bid for $155M in red-hot IPO market
Fierce Biotech
Friday, October 11, 2013 - 9:00am
tags:
IPOs, Celladon, Xencor, Mydicar, XmAb
3 Things Biotech Investors Can't Do With the Government Shutdown
Motley Fool
Friday, October 11, 2013 - 8:58am
tags:
Ariad Pharmaceuticals, Merck, Amarin, advisory panels, FDA
Vivus, Auxilium sign $300 mln deal for erectile dysfunction drug
Reuters
Friday, October 11, 2013 - 8:57am
tags:
Vivus, erectile dysfunction, Auxilium, Stendra
CSL Pays $64M To Settle Antitrust Suit Over Plasma Pricing
Pharmalot
Friday, October 11, 2013 - 8:56am
tags:
CSL, plasma-based pharmaceuticals, antitrust
Alkermes depression drug gets fast track status
Bloomberg/Businessweek
Friday, October 11, 2013 - 8:53am
tags:
Alkermes, fast track, ALKS 5461, antidepressants, major depressive disorder
Make It Or Break It Day Could Be At Hand For Amarin
Seeking Alpha
Friday, October 11, 2013 - 8:51am
tags:
Amarin, FDA, Vascepa
The Big Bucks in Keeping Kids Focused
Bloomberg/Businessweek
Friday, October 11, 2013 - 8:50am
tags:
ADHD, Shire, Vyvanse, Novartis, JNJ, Europe

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.